SCHEMBL30731156

SCHEMBL30731156

N#Cc1[nH]c2ncccc2c1Br

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CHEK1 O14757 2/20 0.49
▸ LRRK2 Q5S007 1/20 0.47
▸ AXL P30530 1/20 0.43
▸ CLK1 P49759 2/20 0.43
▸ CLK2 P49760 2/20 0.43
▸ CDK5 Q00535 2/20 0.43
▸ DYRK1A Q13627 2/20 0.43
▸ CDK5R1 Q15078 2/20 0.43
▸ CLK4 Q9HAZ1 2/20 0.43
▸ DYRK1B Q9Y463 2/20 0.43
▸ CLK3 P49761 1/20 0.43
▸ AURKA O14965 1/20 0.42
▸ PARP1 P09874 1/20 0.42
▸ GPR84 Q9NQS5 1/20 0.42
▸ FEN1 P39748 1/20 0.38
▸ PDK2 Q15119 1/20 0.36
▸ ADORA2A P29274 1/20 0.36
▸ ADORA1 P30542 1/20 0.36
▸ KIF20A O95235 1/20 0.36
▸ RET P07949 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22554147 1.00 CHEK1 (0.49) CHEK1LRRK2AXLCLK1CLK2
SCHEMBL19013425 0.74 AXL (0.44) CHEK1AXLCLK1CLK2CDK5
SCHEMBL857106 0.73 AXL (0.47) CHEK1AXLAURKAPARP1GPR84
SCHEMBL30322758 0.70 AURKA (0.65) CHEK1LRRK2AXLAURKAPARP1
SCHEMBL12396544 0.70 AURKA (0.65) CHEK1LRRK2AXLAURKAPARP1
SCHEMBL31710926 0.69 LRRK2 (0.48) CHEK1LRRK2AXLCLK1CLK2
SCHEMBL23885630 0.69 CHEK1 (0.49) CHEK1LRRK2CLK1CLK2CDK5
SCHEMBL21917176 0.69 CHUK (0.50) CDK5DYRK1ACDK5R1AURKAPARP1
SCHEMBL4070897 0.68 AURKA (0.45) AXLDYRK1ADYRK1BAURKAPARP1
SCHEMBL29621825 0.68 AURKA (0.45) AXLDYRK1ADYRK1BAURKAPARP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-112088157-B Aryl-bipyridylamine derivatives as phosphatidylinositol phosphokinase inhibitors 拉文纳制药公司 2023-12-26 — — CN disclosed
Send feedback